07:00 , Oct 1, 2012 |  BC Week In Review  |  Financial News

Neptune Technologies completes follow-on

Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT; TSX:NTB), Laval, Quebec   Business: Nutraceuticals, Cardiovascular, Neurology   Date completed: 9/25/12   Type: Follow-on   Raised: $30 million   Shares: 7.3 million   Price: $4.10   Underwriters:...
07:00 , Jul 16, 2012 |  BC Week In Review  |  Company News

Merus Labs International, Novartis sales and marketing update

Merus acquired from Novartis rights to manufacture and market overactive bladder (OAB) drug Emselex darifenacin in Canada and the EU, excluding France, Spain and Italy. Merus funded the acquisition with cash on hand and a...